These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 697341)

  • 1. [Action of carminomycin on leukemic cell proliferation and some problems of its use in the combined therapy of leukemias].
    Egorov LV; Khanykova OK; Kuznetsova TV; Rudneva NA; Kozinets GI
    Antibiotiki; 1978 Sep; 23(9):833-6. PubMed ID: 697341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of carminomycin on the kinetics of cell proliferation and some problems of its combined use with other cytostatic agents].
    Egorov LV; Khanykova OK; Kuznetsova TV; Gerasimova NA; Kozinets GI
    Antibiotiki; 1977 Jul; 22(7):639-43. PubMed ID: 883808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
    Khanykova OK; Vinogorova GF
    Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
    Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
    Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of the components of a carminomycin complex].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA; Frankfurt OS
    Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole].
    Vatin AE; Filatov PP
    Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular mechanism of the antileukemic action of quinoline dibromide].
    Golenko OD; Paramonova TD; Nikolaeva TG
    Biull Eksp Biol Med; 1984 Jul; 98(7):59-61. PubMed ID: 6466833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
    Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the antitumor activity of carminomycin in malignant tumors in children (a preliminary report)].
    Durnov LA; Susuleva NA; Lichinitser MR
    Antibiotiki; 1976 Jul; 21(7):654-7. PubMed ID: 782352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytological characteristics of carminomycin-resistant P-388 lymphoid leukosis].
    Kozinets GI; Ivanova E; Kuznetsova TV; Khanykova OK; Levina NV
    Eksp Onkol; 1985; 7(4):60-4, 76. PubMed ID: 4042959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carminomycin induction of single-stranded breaks in the DNA of tumor cells].
    Trenin AS
    Antibiotiki; 1978 May; 23(5):400-3. PubMed ID: 655684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of carminomycin in combination with UHF hyperthermia in the therapy of sarcoma 180].
    Lopatin VF; Dedenkov AN; Vatin AE
    Antibiotiki; 1979 Aug; 24(8):619-22. PubMed ID: 485112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of diazan on the mitotic cycle of leukemia L1210 cells].
    Goncharova SA; Konovalova NP; Shevtsova VN
    Vopr Onkol; 1976; 22(2):68-72. PubMed ID: 1274267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.